The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Non Hodgkin Lymphoma
Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development.
Glioblastoma and children’s brain tumours: teams awarded £18 million Cancer Research UK Brain Tumour Awards
Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.
Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research.
In the news this week: NHS waiting times for cancer treatment ‘continue to spiral downwards’.
A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.
One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.
In the news this week: The low-down from the world’s largest cancer conference and the dangerous documentaries spreading misinformation about cancer.
A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.
An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.